Glioma

Research

Mayo Clinic has a history of brain cancer treatment and research stretching back more than 100 years. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment. The Mayo Clinic Cancer Center is one of three cancer centers to receive a National Cancer Institute-sponsored SPORE grant for brain cancer research.

Scientists in Mayo's Neuro-oncology Program are working to:

• Identify cellular pathways of brain tumor development and progression
• Find and assess proteins (biomarkers) that indicate the presence of tumors and that help predict response to treatments
• Develop new treatment approaches that reduce symptoms and improve survival and quality of life

New treatment approaches include gene therapy to target and kill cancer cells and to disrupt signaling pathways, as well as combination strategies to augment traditional chemotherapy, surgery and radiation therapy.

A central goal is translating research from the laboratory to the clinic, so people can benefit as soon as possible from new discoveries. At Mayo Clinic, you have access to potential leading-edge glioma treatment discoveries through clinical trials.

Publications

See a list of publications by Mayo Clinic authors on glioma on PubMed, a service of the National Library of Medicine.